AUG 01, 2016 5:54 AM PDT

How Lab Grown Brain Tissue Helps Parkinson's Research

When brain tissue is damaged by injury or disease, it’s irreplaceable. Unlike organ transplants or bone and skin grafts, the brain cannot be repaired by sticking on a few new cells. However, in a stunning new research study in Singapore, scientists have made advances in lab created mini versions of mid-brain tissue. Having these small bits of brain tissue will be a huge help for researchers who study Parkinson’s disease, Alzheimer’s and other forms of dementia.
 Lab grown brain tissue could help scientists understand Parkinson's disease
What the lab in Singapore has managed to create are actually three dimensional  miniature versions of certain parts of the human brain. In their study, the results are significant because the tissues grown there have both black pigment neuromelanin and functionally active dopaminergic neurons.
 
The human midbrain is the part of the brain that controls some major functions. Auditory processing, eye movements, vision and muscle movement are the main ones that the mid-brain regulates. Dopaminergic neurons are those that produce dopamine, a substance which is crucial for executive function including motivation, reward and impulse control. Dopamine needs to be balanced because when levels are high, impulsive control suffers and motor activity is increased. Dopamine levels that are too low lead to slower reaction times. In disorders like Parkinson’s disease (PD) dopamine bottoms out and results in the muscle stiffness and difficulty moving that is the hallmark of the disease.
 
Another factor in PD is neuromelanin. In patients with the disease, the tremors they experience are related to cell death in the mid-brain. It’s believed that these cells die from oxidative stress and that neuromelanin has a protective effect against cell death. Parkinson’s patients show a reduction in neuromelanin, so being able to grow tissue that includes it means that research into treatments can take a whole new direction. Given that there are anywhere from seven to 10 million people worldwide who are currently suffering from PD, and the likelihood of that number increasing in coming years, the ability for researchers to use this kind of tissue is groundbreaking. Up until now, any studies on neurodegenerative diseases had to be done using algorithms and simulations or on lab animals. The translation of these studies into human trials has not always been successful. Having actual pieces of brain tissue that are part of the disease process of PD, grown from stem cells, and containing these two key elements will allow researchers a much better foundation for their work.
 
The project was a collaboration of international organizations and scientists, all of whom are leaders in the field of Parkinson’s research.  Prof Ng Huck Hui from A*STAR's Genome Institute of Singapore (GIS) and Assistant Prof Shawn Je from Duke-NUS Medical School were the co-leaders of the project and were assisted by other collaborators from Singapore’s National Neuroscience Institute, the Lieber Institute for Brain Development, the Johns Hopkins University School of Medicine and Nanyang Technological University. It was funded by the Singapore National Medical Research Council's Translational Clinical Research (TCR) Programme In Parkinson's disease (PD) and A*STAR. In a press release, Shawn Je said,  “It is remarkable that our midbrain organoids mimic human midbrain development. The cells divide, cluster together in layers, and become electrically and chemically active in three-dimensional environment like our brain. Now we can really test how these mini brains react to existing or newly developed drugs before treating patients, which will be a game changer for drug development.” The video below has more information on the project.

 Sources:

 A*Star, Duke-NUS Medical School, National Neuroscience Institute
 
The Straits Times
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
JAN 09, 2021
Drug Discovery & Development
Anticoagulant Drugs Prevent Cancer Spreading to Brain
JAN 09, 2021
Anticoagulant Drugs Prevent Cancer Spreading to Brain
Researchers from the Heidelberg University in Germany have found that anticoagulant drugs that inhibit thrombin (an enzy ...
FEB 06, 2021
Neuroscience
Chronic Depression Linked to Reduced Support Cell Function in Brain
FEB 06, 2021
Chronic Depression Linked to Reduced Support Cell Function in Brain
Researchers from Canada have found that people with chronic depression who ultimately commit suicide have significantly ...
APR 29, 2021
Technology
Frequent Social Media Use May Not be a Sign of Addiction, Study Finds
APR 29, 2021
Frequent Social Media Use May Not be a Sign of Addiction, Study Finds
Social media has been a transformative technology, changing many things about our life: the fabric of social movements, ...
MAY 02, 2021
Cannabis Sciences
Medical Cannabis for Epilepsy May Be Linked to Early Puberty
MAY 02, 2021
Medical Cannabis for Epilepsy May Be Linked to Early Puberty
Current research suggests that cannabidiol (CBD) oil may be effective in managing seizures in childhood-onset epilepsy. ...
MAY 10, 2021
Health & Medicine
Scientific Insights Into Romantic Love
MAY 10, 2021
Scientific Insights Into Romantic Love
To better define what romantic love is exactly, social scientists reviewed the literature in the context of biologist Ti ...
MAY 14, 2021
Coronavirus
How COVID-19 Patients Lose Their Sense of Smell
MAY 14, 2021
How COVID-19 Patients Lose Their Sense of Smell
The loss of the sense of smell is a well-known symptom of COVID-19, and was common even in people that did not have many ...
Loading Comments...